Christoph Medler

Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma

W. Klapper, C. Buske, M. Dreyling, 2015, Leukemia.

Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on An Ongoing Phase I/II Trial

M. Dreyling, G. Hess, C. Ruckes, 2011 .

Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma

W. Klapper, M. Dreyling, G. Hess, 2020, HemaSphere.

Temsirolimus in Combination with Bendamustine and Rituximab (BeRT) for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Final Phase I/II Results

M. Dreyling, P. Borchmann, G. Hess, 2016 .

Effects of pentaerythritol tetranitrate on endothelial function in coronary artery disease: results of the PENTA study

T. Münzel, A. Daiber, P. Wenzel, 2010, Clinical Research in Cardiology.